ASPI

ASP Isotopes Inc.

$1.98

-7.48%
SectorBasic MaterialsIndustrySpecialty ChemicalsCountryUnited States

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs.

Source: Yahoo Finance
AI summary

Price & performance

1M-32.4%
3M-47.0%
YTD-63.5%
1Y-79.5%
52-week range—
Beta2.62
Full chart and returns against a benchmark

Q-Score

40/ 100

Quality against peers; 50 is the peer median.

Growth84
Risk29
Performance61
Valuation30
Profitability24
Leverage26
Sentiment85
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$23.8M+475.5%
Net income-$159.8M
Net margin-670.2%+112.2 pts
Historical fundamentals

Red flags in filings

2active red flags
Material weakness in controlsApr 10, 2026
Late filing noticeMay 15, 2026
Filings, findings and the timeline

Revenue exposure

96%of revenue from outside the US
Hong Kong76%
South Africa20%
United States4%
Largest customer32%
Regions, segments, customers and suppliers

Valuation

ASPIIndustryP/E—35.74P/S9.843.46EV/EBITDA—25.76P/B1.154.79PEG—1.57
Dividend yield0.00%
Every valuation metric

Earnings

Nov 12next report
EPS estimate$-0.13
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate